Clinical Trial Update: Radiation Therapy and Durvalumab With or Without Tremelimumab in Treating Participants With Unresectable, Locally Advanced, or Metastatic Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating radiation therapy with durvalumab, with or without tremelimumab, in unresectable, locally advanced, or metastatic bladder cancer; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Durvalumab (durvalumab)
• Tremelimumab (tremelimumab)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Bladder Urothelial Carcinoma, Stage IV Bladder Cancer AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING